MAUDE Adverse Event Report: INTERVASCULAR SAS INTERGARD HEMABRIDGE WOVEN; VASCULAR POLYESTER GRAFT

Model Number	HEW2610BRIDGE
Medical Device Problem Code	Manufacturing, Packaging or Shipping Problem (2975)
Health Effect - Clinical Code	Blood Loss (2597)
Date of Event	02/16/2018
Type of Reportable Event	Serious Injury
Event or Problem Description
It was reported that, on (b)(6) 2018, during a surgery with ecc (extracorporeal circulation) for an aortic aneurysm, a serious bleeding was observed from the graft.The blood loss was about 4k cc and a transfusion was done during the surgery.Thrombocyte and blood plasma cryoprecipitate were used to stop the bleeding.The surgery was prolonged for about 2-3h.The graft remained implanted and, after recovering, the patient was discharged on (b)(6) 2018.No consequence for the patient was reported.
Additional Manufacturer Narrative
The case has been submitted to the corporate medical officer for review, with two other similar cases reported together by the same physician (mdr # 1640201-2018-00009 & 164201-2018-00010).His medical opinion is reported as follows: "we have received three complaints regarding complex aortic surgeries performed at same institution in (b)(6) by the surgeon.Very limited information has been collected regarding the preexisting conditions of the patients.In all cases a very significant blood loss from the totality of the vascular grafts, from 3.5 to 5.5 liters.For all cases hemostatic agents were required to stop the bleeding.The procedures were significantly delayed by the hemostatic management.Ultimately the blood loss was controlled and the graft remained implanted in all cases.Similarly, all patients had no clinically significant consequences due to the events described.The limited information provided don't allow a clinical assessment.However the magnitude of the blood loss was very significant.The cause of the bleeding was unknown.Despite the normal post-operative course, the patients could have experience very serious consequences that could have been life-threatening." the additional information does not modify the conclusions provided in the initial report.
Event or Problem Description
The bleeding was observed from both main body and perfusion branch.

• Brand Name: INTERGARD HEMABRIDGE WOVEN
• Common Device Name: VASCULAR POLYESTER GRAFT
• Manufacturer (Section D): INTERVASCULAR SAS; zi athelia 1; la ciotat cedex, 13705 ; FR 13705
• MDR Report Key: 7341039
• Report Number: 1640201-2018-00008
• Device Sequence Number: 1470422
• Product Code: DSY
• UDI-Device Identifier: 00384401001249
• UDI-Public: 00384401001249
• Combination Product (Y/N): N
• Initial Reporter Country: CH
• PMA/510(K) Number: K013651
• Number of Events Summarized: 1
• Summary Report (Y/N): N
• Device Implanted Year: 2018
• Reporter Type: Manufacturer
• Report Source: company representative
• Initial Reporter Occupation: Physician
• Type of Report: Initial,Followup
• Report Date (Section B): 05/09/2018

1 Device was Involved in the Event

1 Patient was Involved in the Event

• Is this an Adverse Event Report?: Yes
• Is this a Product Problem Report?: Yes
• Operator of Device: No Information
• Device Expiration Date: 03/31/2022
• Device Model Number: HEW2610BRIDGE
• Device Catalogue Number: HEW2610BRIDGE
• Device Lot Number: 17D27
• Was Device Available for Evaluation?: No
• Was the Report Sent to FDA?: No
• Initial Date Received by Manufacturer: 02/16/2018
• Supplement Date Received by Manufacturer: 04/24/2018
• Initial Report FDA Received Date: 03/15/2018
• Supplement Report FDA Received Date: 05/09/2018
• Is This a Single-Use Device that was Reprocessed and Reused on a Patient? (Y/N): No
• Patient Sequence Number: 1
• Outcome Attributed to Adverse Event: Required Intervention
• Patient Age: 65 YR